Search results for "cardiovascular risks"
Indications added for Gardasil, breast implants questioned
Recalls, warnings, and approvals.
https://immattersacp.org/archives/2011/04/fda.htm
1 Apr 2011
Non-aspirin NSAIDs associated with risk for atrial fibrillation or flutter, study finds
Nonselective nonsteroidal anti-inflammatory drugs (NSAIDs) and selective cyclooxygenase (COX)-2 inhibitors may be associated with increased risk for atrial fibrillation or flutter, according to a new study.
https://immattersacp.org/weekly/archives/2011/07/12/2.htm
12 Jul 2011
ADHD drugs appear to present no cardiovascular risks in adults
Attention-deficit/hyperactivity disorder medications were not associated with an increased risk of serious cardiovascular events among young and middle-aged adults, researchers found.
https://immattersacp.org/weekly/archives/2011/12/20/2.htm
20 Dec 2011
‘Goldilocks' goal for diabetes and CKD
Managing kidney disease in diabetes requires meeting individualized parameters and balancing risks in nephrology and cardiology. Learn whether more aggressive treatment is warranted in this population.
https://immattersacp.org/archives/2012/11/diabetes.htm
1 Nov 2012
Sulfonylureas associated with higher CV risk than metformin
As initial monotherapy for type 2 diabetes, sulfonylureas were associated with more cardiovascular events and deaths than metformin, a new study found.
https://immattersacp.org/weekly/archives/2012/11/06/1.htm
6 Nov 2012
Long-acting beta-agonists and anticholinergics pose similar cardiovascular risks
Patients with chronic obstructive pulmonary disease (COPD) faced increased risk of a cardiovascular event after starting treatment with a long-acting bronchodilator, whether it was a beta-agonist or an anticholinergic, a new study found.
https://immattersacp.org/weekly/archives/2013/06/04/4.htm
4 Jun 2013
Pearls for lowering lipids
New guidelines recommend basing treatment decisions on levels of risk rather than LDL targets.
https://immattersacp.org/archives/2016/07/lipids.htm
1 Jul 2016
A ‘smart’ approach to performance drugs
An increasing prevalence of the use of cognitive-enhancing substances, or so-called “smart drugs,” among healthy people has raised concerns among internists and medical ethicists.
https://immattersacp.org/archives/2017/11/a-smart-approach-to-performance-drugs.htm
1 Nov 2017
Calculate ‘sum of the parts' to pinpoint CV risk in women
Women face a steep increase in cardiovascular risk after menopause, requiring internists to incorporate composite indicators into the annual exam at midlife.
https://immattersacp.org/archives/2018/01/calculate-sum-of-the-parts-to-pinpoint-cv-risk-in-women.htm
1 Jan 2018
Migraine associated with cardiovascular risks
Higher absolute risks of cardiovascular disease were observed among patients with migraine across most outcomes and follow-up periods during 19 years of follow-up.
https://immattersacp.org/weekly/archives/2018/02/06/4.htm
6 Feb 2018